Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/29138
Title: | The Emerging Role of Triggering Receptor Expressed on Myeloid Cells 2 as a Target for Immunomodulation in Ischemic Stroke | Authors: | GERVOIS, Pascal LAMBRICHTS, Ivo |
Issue Date: | 2019 | Publisher: | FRONTIERS MEDIA SA | Source: | FRONTIERS IN IMMUNOLOGY, 10 (Art N° 1668) | Abstract: | Stroke is the second most common cause of death and permanent disability. It is characterized by loss of neural tissue in which inflammation plays a crucial role in both the acute contribution to ischemic damage as in the late-stage impact on post-ischemic tissue regeneration. Microglia play a key role in the inflammatory stroke microenvironment as they can adapt a disease-promoting pro-inflammatory- or pro-regenerative phenotype thereby contributing to the exacerbation or alleviation of ischemic damage, respectively. Triggering receptor expressed on myeloid cells 2 (TREM2) is a cell surface receptor which in the central nervous system is mainly expressed on microglia. This receptor has been shown to play an essential role in microglial phagocytosis and function but its contribution in stroke pathobiology remains unclear. TREM2 was shown to be activated by nucleotides and lipidmediators, key factors that are secreted in the extracellular stroke environment by apoptotic neurons and cell/myelin debris. These factors in turn stimulate TREM2 signaling which mediates microglial migration toward- and phagocytosis of myelin debris and apoptotic cells. Moreover, microglial TREM2 appears to counteract the toll-like receptor response, thereby decreasing the production of pro-inflammatory cytokines. Finally, TREM2 is involved in microglial migration, survival, and is suggested to directly stimulate pro-regenerative phenotype shift. Therefore, this receptor is an attractive target for microglial modulation in the treatment of ischemic stroke and it provides additional information on microglial effector functions. This short review aims to elaborate on these TREM2-mediated microglial functions in the pathobiology and resolving of ischemic stroke. | Notes: | [Gervois, Pascal; Lambrichts, Ivo] Hasselt Univ, Biomed Res Inst, Dept Morphol, Diepenbeek, Belgium. | Keywords: | ischemic stroke; microglia; TREM2; immunomodulation; phagocytosis;ischemic stroke; microglia; TREM2; immunomodulation; phagocytosis | Document URI: | http://hdl.handle.net/1942/29138 | ISSN: | 1664-3224 | e-ISSN: | 1664-3224 | DOI: | 10.3389/fimmu.2019.01668 | ISI #: | 000475828300002 | Rights: | open access. | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2020 |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
gervois 1.pdf | Published version | 658.4 kB | Adobe PDF | View/Open |
SCOPUSTM
Citations
6
checked on Sep 3, 2020
WEB OF SCIENCETM
Citations
45
checked on Oct 13, 2024
Page view(s)
112
checked on Aug 31, 2022
Download(s)
166
checked on Aug 31, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.